Overview

A patient-focused platform designed to explain CTCL, a rare form of blood cancer, in a way that was clear, approachable, and clinically accurate. Delivered in partnership with a cross-functional team for global biopharma company Kyowa Kirin.

Challenge

CTCL is a complex, often misunderstood condition. Patients needed a resource that could simplify medical information without feeling overwhelming, so clarity and sensitivity were crucial, all within strict healthcare compliance constraints.

Solution

I led the design of the full digital experience, from initial brand identity and storyboards through to responsive layouts and print materials. Working closely with a creative director and medical stakeholders, I developed a tone and visual system that balanced empathy with clarity.

Results

The project received glowing feedback from both patients and healthcare professionals. It went on to win Gold at the 2023 PM Society Digital Awards in the Patient Programmes category, validating the success of our human-centred approach.